Vaired module row
Title
Description
Gradient
Description
We believe bioelectronic medicines could allow us to address some diseases that have so far been untreatable, and others with greater precision and fewer side effects than with conventional molecular medicines.
We have dedicated significant resources trying to industrialise the process we use to manufacture the trial Ebola vaccine, so we can make it in large quantities. Some major challenges continue to face us in scaling up the production of this vaccine: just filling vials with trial Ebola vaccine under the sterile conditions required, for example, without derailing the production of other life-saving vaccines that are extremely important for public health.
If the vaccine proves successful, we’ll work closely with our partners to make sure it gets to the people who need it. I’m pleased that we are seeing groups like Gavi, [1] the Global Vaccine Alliance for Immunisation, make funds available for future Ebola vaccines.
It is likely that Ebola will return in the affected countries or others in the region because the virus is endemic and cannot be eradicated completely. What the global public health community is learning through the emergency response, though, is that together we can hope to be able to tackle Ebola.
While our experience will be invaluable in our response to any and all future Ebola outbreaks, the global community must design and implement more proactive preparedness approaches to further improve our capacity to prevent and/or quickly control unpredictable disease outbreaks such as Ebola, but also SARS, Pandemic Flu and many others…
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
Careers
Test
Lorem ipsum dolor sit amet
title
Test
- 234
